Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia (Q46463073)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia |
scientific article published in July 2008 |
Statements
1 reference
Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia (English)
1 reference
Walter F Riesen
1 reference
Georg Noll
1 reference
Roger Dariolo
1 reference
ORBITAL trialists
1 reference
1 July 2008
1 reference
1 reference
138
1 reference
29-30
1 reference
420-426
1 reference